Shanghai Pharmaceuticals Holding Co., Ltd
Symbol: 601607.SS
SHH
18.21
CNYTržní cena dnes
17.7420
Poměr P/E
1.0392
Poměr PEG
55.48B
MRK Cap
- 0.03%
Výnos DIV
Shanghai Pharmaceuticals Holding Co., Ltd (601607-SS) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 40669.9 | 37015 | 22390.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 11197.2 | 9613.6 | -1242.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 81003.7 | 76634 | 65885.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 36623.4 | 34460.2 | 27104 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 4136.9 | 1403.7 | 1114.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 162433.9 | 149512.9 | 116494.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18278.7 | 16185.3 | 15390.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 11393.3 | 11335.9 | 11239 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 6361.3 | 6586.7 | 6308.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 17754.7 | 17922.7 | 17547.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 11145.3 | 1863.6 | 11778.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 1716.9 | 1534.7 | 1367.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 643.1 | 11115.7 | 856.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 49538.7 | 48622 | 46941.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 211972.5 | 198134.9 | 163435.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47915 | 51565.5 | 41995.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 51217.4 | 31000 | 23096.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 809.8 | 1440.8 | 1692.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5786.2 | 7561.4 | 8592 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 67.4 | 534.6 | 2349.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 21268.8 | 25882.7 | 9232.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8708.5 | 9441.4 | 12545 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1550.1 | 1301.6 | 1434.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 131080.4 | 120132.5 | 104369.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 3703.3 | 3697.5 | 2842.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 33822.3 | 32479.9 | 28598.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1532.1 | 1553.9 | 1565.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 29466.4 | 29331.7 | 16353.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 68524.1 | 67063 | 49359.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 211972.5 | 198134.9 | 163435.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 11801.9 | 10939.4 | 9706.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 80326.1 | 78002.5 | 59066.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 0 | 22342.5 | 11477.2 | 10535.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 58553.6 | 38561.4 | 31688.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 29080.9 | 11160 | 9298.3 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 3768 | 6992 | 6274.6 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 2361.2 | 2222.4 | 2139.8 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -194.8 | -131.9 | 165 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -8873.1 | 22 | 31.3 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -4150.7 | -4680 | -3398.7 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -6432.4 | -10081.4 | -6155.5 | ||||||||||||||||||||||||||
cash-flows.row.inventory | 0 | -2303.8 | -7111.7 | -3201 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 4585.5 | 12645 | 5792.8 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -131.9 | 165 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 13303.7 | 318.9 | -150.7 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2970.6 | -2684.9 | -4118.8 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1162 | 22.5 | -1039.3 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -28423.1 | -39683.8 | -3147.8 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 27986.8 | 30267 | 3288.2 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 1270.7 | -394 | -997.8 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3298.2 | -12473.1 | -6015.6 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -6855 | -59808.7 | -52214.6 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2259 | -3093.9 | -2675.9 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 9169.4 | 75041.2 | 56456.1 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 55.4 | 12138.6 | 1565.6 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -5.6 | -12.4 | -50.3 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 3152.7 | 4396.4 | 561.1 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 29472.7 | 24533.9 | 20137.5 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 26320.1 | 20137.5 | 19576.4 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 6214.3 | 4743.4 | 5061.3 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2970.6 | -2684.9 | -4118.8 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 3243.7 | 2058.5 | 942.6 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 259557 | 231981.3 | 215824.3 | |||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 230524.4 | 201494.9 | 187281.1 | |||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 29032.6 | 30486.4 | 28543.1 | |||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -310 | 4117.5 | 3901.4 | |||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 20837.5 | 21705.4 | 20616.2 | |||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 251361.9 | 223200.3 | 207897.3 | |||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | -461.8 | 438.3 | 338.2 | |||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1885 | 1689.3 | 1518.2 | |||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1270.2 | -206.3 | -61.7 | |||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -310 | 4117.5 | 3901.4 | |||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1270.2 | -206.3 | -61.7 | |||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1885 | 1689.3 | 1518.2 | |||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 2361.2 | 2990.9 | 3756 | |||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 8195.1 | 9014.7 | 8205.5 | |||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 6925 | 8808.4 | 8143.8 | |||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1887.7 | 1816.3 | 1869.2 | |||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 3768 | 5617.2 | 5093.5 |
Často kladené otázky
Co je Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) celková aktiva?
Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) celková aktiva jsou 211972533766.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.113.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.102.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.014.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.028.
Co je Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 3767999581.000.
Jaký je celkový dluh podniku?
Celkový dluh je 58553624884.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 20837465592.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.